Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free Anesthesia in Supratentorial Tumor Resection
NCT06607029Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine and dexmedetomidine in Supratentorial tumor (STT) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Quality of Recovery-15 Score at Day 2. Started Oct 2024; status: recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
Supratentorial tumor (STT)
Beyond the preview
Go deeper on NCT06607029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06607029.